Evaluate the Preliminary Efficacy, Safety, and PK of Subcutaneous JS005 in Chinese Adult Patients With Active AS
Clinical trial NCT05212051 · COMPLETED
Trial details
- NCT number
- NCT05212051
- Sponsor
- Shanghai Junshi Bioscience Co., Ltd.
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2021-04-01
- Primary completion
- 2022-12-28
- Enrollment
- 131
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.